Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
GlycoPharma Holding ApS
APS
Active
Advertising protection
CVR 39691558
Rørhatten 4, 5220
Odense SØ
Activities of holding companies
·
NACE 6421
Est. 2018 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
GlycoPharma Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AB
Anders Boysen
Management
Management
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Boysen Bio ApS — 33.33–49.99%
Zahle Holding ApS — 15–19.99%
Bioglyco ApS — 10–14.99%
JMJ Holding ApS — 10–14.99%
Røssel Invest APS — 10–14.99%
SCIENCE VENTURES DENMARK A/S — 5–9.99%
83–100%
Shareholder
Type
Ownership
Votes
Since
Boysen Bio ApS
Company
33.33–49.99%
33.33–49.99%
2018
Zahle Holding ApS
Company
15–19.99%
15–19.99%
2018
Bioglyco ApS
Company
10–14.99%
10–14.99%
2018
JMJ Holding ApS
Company
10–14.99%
10–14.99%
2018
Røssel Invest APS
Company
10–14.99%
10–14.99%
2018
SCIENCE VENTURES DENMARK A/S
Company
5–9.99%
5–9.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on GlycoPharma Holding ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
